Adverum Biotechnologies
(NASDAQ) ADVM
Adverum Biotechnologies Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$204.39M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
ADVM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Adverum Biotechnologies
Industry
Biotechnology
Sector
Health CareEmployees
155
CEO
Laurent Fischer, MD
Website
www.adverum.comHeadquarters
Redwood City, CA 94063, US
ADVM Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-38%
Return on Capital
-7%
Return on Assets
-3%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$1.00M
Operating Income
$139.16M
EBITDA
$135.51M
Operating Cash Flow
$92.46M
Capital Expenditure
$388.00K
Free Cash Flow
$92.85M
Cash & ST Invst.
$125.69M
Total Debt
$91.70M
Adverum Biotechnologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$465.00K
-146.5%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
155
N/A
Net Income
$47.65M
-75.6%
EBITDA
$47.19M
-66.6%
Quarterly Fundamentals
Net Cash
$62.88M
-178.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$83.13M
+32.8%
Short Term Debt
$5.81M
-45.5%
Return on Assets
-2.82%
N/A
Return on Invested Capital
-7.50%
N/A
Free Cash Flow
$28.26M
-32.4%
Operating Cash Flow
$28.11M
-33.1%